Newbridge Financial Services Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-250
Closed -$25.4K 1208
2025
Q4
$25.4K Sell
250
-300
-55% -$24.1K ﹤0.01% 583
2025
Q3
$30.1K Hold
550
﹤0.01% 639
2025
Q2
$29.2K Hold
550
﹤0.01% 622
2025
Q1
$23.8K Hold
550
0.01% 508
2024
Q4
$30.9K Hold
550
0.01% 519
2024
Q3
$37.5K Hold
550
0.01% 287
2024
Q2
$23.2K Hold
550
0.01% 547
2024
Q1
$38K Hold
550
0.02% 454
2023
Q4
$40.7K Buy
550
+50
+10% +$3.28K 0.02% 441
2023
Q3
$34.1K Buy
+500
New +$42.4K 0.02% 515
2022
Q2
Sell
-835
Closed -$58K 1401
2022
Q1
$58K Buy
835
+469
+128% +$34.3K 0.03% 438
2021
Q4
$28K Buy
+366
New +$32.3K 0.01% 624
2021
Q3
Sell
-439
Closed -$55K 1456
2021
Q2
$55K Sell
439
-140
-24% -$16.7K 0.03% 413
2021
Q1
$76K Buy
+579
New +$79.3K 0.06% 303

Other funds holding EXAS

Newbridge Financial Services Group's EXAS Position: Q1 2026 in Review

Newbridge Financial Services Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 250 shares — an estimated $25.4K sold.

Newbridge Financial Services Group first reported a position in EXAS in Q1 2021 and held it in 14 quarters. The position peaked at $76K in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Newbridge Financial Services Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Newbridge Financial Services Group sold 250 Exact Sciences shares in Q1 2026, an estimated $25.4K.
  • Newbridge Financial Services Group first reported a position in Exact Sciences in Q1 2021 and held it in 14 quarters.
  • Newbridge Financial Services Group's Exact Sciences position peaked at $76K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.